PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
68.88%
Positive revenue growth while CVE is negative. John Neff might see a notable competitive edge here.
144.69%
Positive gross profit growth while CVE is negative. John Neff would see a clear operational edge over the competitor.
2810.71%
Positive EBIT growth while CVE is negative. John Neff might see a substantial edge in operational management.
2810.71%
Positive operating income growth while CVE is negative. John Neff might view this as a competitive edge in operations.
7116.67%
Positive net income growth while CVE is negative. John Neff might see a big relative performance advantage.
7112.99%
Positive EPS growth while CVE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
7236.56%
Positive diluted EPS growth while CVE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.04%
Share count expansion well above CVE's 0.01%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-1.80%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-4.04%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-22.47%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-243.59%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-57.55%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
23.45%
Positive 5Y CAGR while CVE is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
52.64%
Positive 3Y CAGR while CVE is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
141.75%
Positive long-term OCF/share growth while CVE is negative. John Neff would see a structural advantage in sustained cash generation.
-31.50%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
299.96%
Positive 3Y OCF/share CAGR while CVE is negative. John Neff might see a big short-term edge in operational efficiency.
-83.91%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
114.39%
Positive 5Y CAGR while CVE is negative. John Neff might view this as a strong mid-term relative advantage.
-26.83%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-67.37%
Negative equity/share CAGR over 10 years while CVE stands at 9.53%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-37.53%
Negative 5Y equity/share growth while CVE is at 0.72%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
16.99%
3Y equity/share CAGR above 1.5x CVE's 2.63%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-90.83%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-63.16%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
19.85%
3Y dividend/share CAGR at 50-75% of CVE's 27.35%. Martin Whitman might see a weaker short-term approach to distributing cash.
4.80%
Our AR growth while CVE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
0.08%
Positive asset growth while CVE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.59%
Positive BV/share change while CVE is negative. John Neff sees a clear edge over a competitor losing equity.
-2.20%
We’re deleveraging while CVE stands at 10.39%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
2038.10%
We expand SG&A while CVE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.